Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,273,537
+$227,314 QoQ
Shares Held
25,475
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,287
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. MRK ranks #6 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,273,537 | 25,475 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,046,223 | 25,324 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,698,024 | 25,632 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,176,304 | 25,930 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,084,520 | 26,333 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,414,364 | 26,898 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,646,168 | 26,600 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,043,294 | 26,799 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,308,307 | 26,723 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,621,103 | 27,443 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,084,393 | 28,292 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,929,957 | 28,460 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,295,423 | 28,559 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,055,839 | 28,723 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,258,823 | 29,372 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,549,152 | 29,600 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,707,657 | 29,699 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,457,233 | 29,948 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,354,304 | 30,719 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,308,505 | 30,735 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,427,046 | 31,208 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,378,767 | 30,857 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $812,519 | 9,933 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $823,776 | 9,931 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $767,887 | 9,930 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $763,936 | 9,929 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||